The widely prescribed statin, simvastatin, can medically help patients with secondary progressive Multiple Sclerosis (SPMS)—for reasons that might be unrelated to the drug's intended cholesterol lowering affects, a UCL ...
May 10, 2019
2
244
Two commonly prescribed statins appear to be associated with a higher risk of bleeding than others when combined with dabigatran, a drug often used for preventing strokes in patients with atrial fibrillation, according to ...
Nov 21, 2016
0
27
Statins are a hugely popular drug class used to manage blood cholesterol levels and reduce the risk of heart disease. Previous studies had raised questions about adverse behavioral changes with statins, such as irritability ...
Jul 1, 2015
0
106
The United States Food and Drug Administration (FDA) today announced new limitations to the use of high-dose simvastatin, due to the increased risk of muscle pain and weakness (myopathy) and in rare cases, kidney damage and ...
Jun 9, 2011
1
0
A dose of the drug simvastatin results in cognitive improvement in people with secondary progressive multiple sclerosis (SPMS), according to research published in The Lancet Neurology.
Jun 8, 2017
0
148
(HealthDay)—Cholesterol-lowering therapy with simvastatin reduces the physiological responses to aerobic exercise training in overweight or obese adults who are at increased risk for metabolic syndrome, according to research ...
Jun 28, 2013
0
0
In the United States, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who have private insurance is approximately 400 percent higher than comparable costs paid by the government in the ...
Jan 5, 2012
12
0
Treatment with high potency statins (especially atorvastatin and simvastatin) may increase the risk of developing diabetes, suggests a paper published today in BMJ.
May 23, 2013
0
0
(HealthDay) -- Use of diagnostic codes, such as International Classification of Diseases -- Ninth Revision (ICD-9) codes, may result in misclassification of rare, adverse drug reactions (ADRs), including the risk of rhabdomyolysis ...
Apr 18, 2012
0
0
In a study of more than 1,000 adults, researchers at the University of California, San Diego, found that individuals taking cholesterol-lowering statin drugs are more likely than non-users to experience decreased energy, ...
Jun 11, 2012
0
0
